MY-RIDE Program for HIV Prevention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether the MY-RIDE program (Motivating Youth to Reduce Infections, Disconnections, and Emotion dysregulation) can reduce substance use and enhance HIV prevention efforts. The researchers aim to determine if the program increases willingness to take PrEP (a medication that helps prevent HIV), manage stress, and utilize mental health and substance use services. Participants will either follow the MY-RIDE program or join a comparison group. Suitable candidates for this trial are English-speaking individuals experiencing homelessness who have used substances, recently engaged in sexual activity, and plan to remain in the metro area for the next 15 months. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could shape future HIV prevention strategies.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators.
What prior data suggests that the MY-RIDE program is safe for youth?
Research has shown that the MY-RIDE program helps young people manage their emotions to reduce risky behaviors. The program includes short messages aimed at improving HIV prevention and reducing substance use among youth. While specific information on side effects or negative reactions related to MY-RIDE is not available, the program is non-invasive. This means it does not involve taking medicine or undergoing medical procedures, which typically lowers the chance of physical side effects. The trial is in a phase called "Not Applicable," focusing on changing behaviors rather than testing a new drug, which generally presents fewer safety risks. Participants in similar studies have usually responded well to this type of program.12345
Why are researchers excited about this trial?
Researchers are excited about the MY-RIDE Program for HIV prevention because it offers a novel approach compared to traditional methods like PrEP medications. Unlike the standard of care, which typically involves daily pill regimens, MY-RIDE focuses on behavioral intervention through personalized, interactive sessions designed to empower individuals and promote safer practices. This program could enhance engagement and adherence, potentially leading to more effective prevention strategies.
What evidence suggests that the MY-RIDE program is effective for HIV prevention?
Research has shown that the MY-RIDE program, which participants in this trial may receive, helps young people manage their emotions to reduce risky behaviors. It aims to lower substance use and promote HIV prevention strategies. Studies suggest that MY-RIDE may also increase the willingness to use PrEP, a medication that helps prevent HIV. Early results have been promising in improving mental health and reducing the urge to use substances. Overall, MY-RIDE is designed to help youth make safer health choices by teaching them to better control their emotions.12367
Who Is on the Research Team?
Diane M Santa Maria, DrPH, MSN, RN, PHNA-BC, FSAHM
Principal Investigator
The University of Texas Health Science Center, Houston
Are You a Good Fit for This Trial?
This trial is for English-speaking youth experiencing homelessness in the metro area, who have used substances and been sexually active recently or plan to be. They should not be planning to move during the study year and must be able to read well enough (RELM-SF score ≥ 4).Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the MY-RIDE intervention to improve HIV prevention and reduce substance use
Follow-up
Participants are monitored for changes in STIs and PrEP uptake
What Are the Treatments Tested in This Trial?
Interventions
- Attention-control group
- MY-RIDE
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Health Science Center, Houston
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator